ALS, FDA and Amylyx
Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...
When a renowned Israeli TV journalist lost his ability to speak clearly because of ALS, he thought his career might be over.
Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...
Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...
Zydus’ Usnoflast receives US FDA orphan drug designation to treat amyotrophic lateral sclerosis: Our Bureau, Mumbai Thursday, January 23, 2025, 12:15 Hrs [IST] Zydus, a leading, ...
Artificial-intelligence software is being used to re-create Moshe Nussbaum's widely recognized, distinctive voice ...
A New Bedford man was sentenced to prison for conspiring to steal and then depositing over $450,000 from a U.S. Marine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback